Showing results (1661-1670 of 2,572) with videos related to

Sort By:
Pageof 258
CPT: Pharmacometrics & Systems Pharmacology|May 31, 2017
Dissociated Agonist of Glucocorticoid Receptor or Prednisone for Active Rheumatoid Arthritis: Effects on P1NP and Osteocalcin PharmacodynamicsS Shoji, A Suzuki, D J Conrado, et al.
Clinical and Experimental Pharmacology & Physiology|July 14, 2018
Effects of neuromuscular presynaptic muscarinic M1 receptor blockade on rocuronium-induced neuromuscular blockade in immobilized tibialis anterior musclesYong Beom Kim, Hong-Seuk Yang, Ha Jung Kim, et al.
Biostatistics (Oxford, England)|March 31, 2015
A stochastic transcriptional switch model for single cell imaging dataKirsty L Hey, Hiroshi Momiji, Karen Featherstone, et al.
Cytotherapy|May 16, 2023
Small extracellular vesicles from mesenchymal stromal cells: the next therapeutic paradigm for musculoskeletal disordersKristeen Ye Wen Teo, Rachel Tan, Keng Lin Wong, et al.
Stem Cells International|December 23, 2011
Spleen as a site for hematopoiesis of a distinct antigen presenting cell typeHelen C O'Neill, Kristin L Griffiths, Pravin Periasamy, et al.
Pediatrics|December 13, 2019
Successful Use of Cidofovir in an Immunocompetent Child With Severe Adenoviral SepsisAlicia M Alcamo, Michael S Wolf, Lauren J Alessi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 8, 2014
Rebound potentiation of inhibition in juvenile visual cortex requires vision-induced BDNF expressionMing Gao, Kristen R Maynard, Varun Chokshi, et al.
Chemmedchem|January 11, 2013
2-Carbaborane-3-phenyl-1H-indoles--synthesis via McMurry reaction and cyclooxygenase (COX) inhibition activityMarkus Laube, Wilma Neumann, Matthias Scholz, et al.
Journal of the American College of Surgeons|June 18, 2013
AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment?Danielle M Hari, Anna M Leung, Ji-Hey Lee, et al.
Hormone Research in Paediatrics|September 12, 2013
A four-year, open-label, multi-center, randomized, two-arm study of Genotropin® in patients with idiopathic short stature: comparison of an individualized, target-driven treatment regimen to standard dosing of Genotropin® - analysis of two-year dataD R Counts, L A Silverman, M E Geffner, et al.
Pageof 258